Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven research firms that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month […]
BMO Capital Markets reissued their outperform rating on shares of Centessa Pharmaceuticals (NASDAQ:CNTA – Free Report) in a research report report published on Monday morning, Benzinga reports. BMO Capital Markets currently has a $15.00 price objective on the stock. Centessa Pharmaceuticals Stock Performance Shares of CNTA stock opened at $10.37 on Monday. The business has […]
Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) fell 5.6% during mid-day trading on Monday . The stock traded as low as $11.48 and last traded at $11.52. 351,020 shares traded hands during trading, a decline of 16% from the average session volume of 419,941 shares. The stock had previously closed at $12.20. […]
Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) have earned an average rating of “Moderate Buy” from the eight brokerages that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month […]
Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven brokerages that are presently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 […]